Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-22T04:08:31.996Z Has data issue: false hasContentIssue false
  • English
  • Français

Are UK healthcare professionals equipped to provide information and support on Human Papillomavirus to patients diagnosed with cancer of the head and neck?

Published online by Cambridge University Press:  04 December 2020

R. Jopson Open the ORCID record for R. Jopson [Opens in a new window]  and
J. Callender
R. Jopson*
Affiliation:
Radiotherapy programme, School of Health Sciences, University of Liverpool, The Quadrangle, Brownlow Hill, Liverpool, UK Radiotherapy department, Rosemere Cancer Centre, Royal Preston Hospital, Sharoe Green Lane, Preston, UK
J. Callender
Affiliation:
Radiotherapy programme, School of Health Sciences, University of Liverpool, The Quadrangle, Brownlow Hill, Liverpool, UK Radiotherapy department, Rosemere Cancer Centre, Royal Preston Hospital, Sharoe Green Lane, Preston, UK
*
Author for correspondence: R. Jopson, Radiotherapy department, Rosemere Cancer Centre, Royal Preston Hospital, Sharoe Green Lane, Preston, UK. Tel.: 01772522900. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Aim:

Incidence rates of Human Papillomavirus (HPV) positive head and neck cancer (HNC) are increasing. The aim of this study was to explore the availability of information and the knowledge and confidence of healthcare professionals (HCPs) involved in the cancer pathway to provide information on HPV to patients.

Materials and method:

An online questionnaire was designed using closed and open questions to investigate the availability of patient information for patients diagnosed with HPV-associated HNC; health professional’s knowledge of the information available; and their confidence in discussing the topic. The questionnaire was advertised to health professionals through the British Association of Head and Neck Oncologists website. Twenty-five health professionals from six professions across five UK Cancer Alliances completed the questionnaire between November and December 2018.

Results:

Nearly half of the participants did not know whether patients were routinely provided with information on HPV following an HPV-positive (HPV+) cancer diagnosis; 52% indicated that specific information was available within their hospital trust, however, there were inconsistencies with participants’ knowledge of the content of the information leaflets currently available. On a scale of 1–100, the mean confidence in providing HPV-related information was 58.

Findings:

Inconsistencies appear to exist with respect to information about HPV available to patients presenting with HNC. A need has been identified for the education of health professionals involved in the patient care to support information provision.

Keywords

CPDeducationHuman Papillomavirushead and neckpatient information
Type
Original Article
Information
Journal of Radiotherapy in Practice , Volume 21 , Issue 2 , June 2022 , pp. 165 - 170
Check for updates
Copyright
© The Author(s), 2020. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Tong, F, Geng, J, Yan, B et al. Prevalence and prognostic significance of HPV in laryngeal squamous cell carcinoma in Northeast China. Cell Physiol Biochem. 2018; 49: 206–216.CrossRefGoogle ScholarPubMed
Vázquez-Otero, C, Vamos, C, Thompson, E et al. Assessing dentists’ human papillomavirus–related health literacy for oropharyngeal cancer prevention. J Am Dent Assoc. 2018; 149 (1): 9–17.CrossRefGoogle ScholarPubMed
Gillison, M, D’Souza, G, Westra, W et al. Distinct risk factor profiles for human papillomavirus type 16–positive and human papillomavirus type 16–negative head and neck cancers. J Natl Cancer Inst. 2008; 100 (6): 407–420.CrossRefGoogle ScholarPubMed
Schache, A, Powell, N, Cuschieri, K et al. HPV-related oropharynx cancer in the United Kingdom: an evolution in the understanding of disease etiology. Cancer Res. 2016; 76 (22): 6598–6606.CrossRefGoogle ScholarPubMed
Lechner, M, Vassie, C, Kavasogullari, C et al. A cross-sectional survey of awareness of human papillomavirus-associated oropharyngeal cancers among general practitioners in the UK. Br Med J. 2018; 8 (7): e023339.Google ScholarPubMed
Evans, M, Powell, N. Sexual health in oral oncology: breaking the news to patients with human papillomavirus-positive oropharyngeal cancer. Head Neck. 2014; 36 (11): 1529–1533.CrossRefGoogle ScholarPubMed
Yang, F, Yin, Y, Li, P et al. Prevalence of human papillomavirus type-18 in head and neck cancer among the Chinese population. Medicine. 2019; 98 (8): e14551.CrossRefGoogle ScholarPubMed
Nguyen, N, Nguyen, L, Thomas, S et al. Oral sex and oropharyngeal cancer. Medicine. 2016; 95 (28): e4228.CrossRefGoogle ScholarPubMed
NHS. HPV Vaccination Overview. [Internet] 2020. Available from: https://www.nhs.uk/conditions/vaccinations/hpv-human-papillomavirus-vaccine/. Accessed on 8th October 2020Google Scholar
Neal, A, Hoskin, P. Clinical Oncology. Basic Principles and Practice. Fourth Edition. London: CRC Press; 2012.Google Scholar
Cancer Research UK. CRUK/11/043. De-ESCALaTE HPV: Determination of Epidermal growth factor receptor inhibitor (cetuximab) versus Standard Chemotherapy (cisplatin) early And Late Toxicity Events in Human Papillomavirus-positive oropharyngeal squamous cell carcinoma. [Internet] 2019. Available from: http://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/atrial-looking-side-effects-treatment-throat-cancer-de-escalate-hpv. Accessed on 26th May 2020Google Scholar
Cancer Research UK. CRUK/13/025. Post-operative adjuvant treatment for HPV-positive tumours (PATHOS). [Internet] 2020. Available at: http://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/atrial-looking-at-treatment-after-surgery-for-hpv-positive-oropharyngeal-cancer-pathos. Accessed on 26th May 2020Google Scholar
Mehanna, H, Robinson, M, Hartley, A et al. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. Lancet Glob Health. 2019; 393 (10166): 51–60.Google ScholarPubMed
National Institute for Heath and Care Excellence (NICE). NICE Guidance: Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over [Internet]. 2018. Available from: https://www.nice.org.uk/guidance/ng36/chapter/Recommendations#hpvrelated-disease. Accessed on 26th May 2020Google Scholar
Reich, M, Licitra, L, Vermorken, J et al. Best practice guidelines in the psychosocial management of HPV-related head and neck cancer: recommendations from the European Head and Neck Cancer Society’s Make Sense Campaign. Ann Oncol. 2016; 27 (10): 1848–1854.CrossRefGoogle ScholarPubMed
Guo, T, Goldenberg, D, Fakhry, C. AHNS series: Do you know your guidelines? Management of head and neck cancer in the era of human papillomavirus: Educating our patients on human papillomavirus. Head Neck. 2017; 39 (5): 833–839.CrossRefGoogle Scholar
Baker, P. Talking to patients and their families: A guide for clinicians and other health professionals. The Throat Cancer Foundation; 2018.Google Scholar
Baker, P. HPV and Throat Cancer: Information for Patients and their Families. The Throat Cancer Foundation; 2018 Google Scholar
Boynton, P. Administering, analysing and reporting your questionnaire. Br Med J. 2004; 328 (7452): 1372–1375.CrossRefGoogle ScholarPubMed
British Association of Head and Neck Oncologists [Internet]. Bahno.org.uk. 2020. Available from: https://www.bahno.org.uk/. Accessed on 23rd June 2020.Google Scholar
Dodd, R, Waller, J, Marlow, L. Human papillomavirus and head and neck cancer: psychosocial impact in patients and knowledge of the link – a systematic review. J Clin Oncol. 2016; 28 (7): 421–439.CrossRefGoogle ScholarPubMed
D’Souza, G, Zhang, Y, Merritt, S et al. Patient experience and anxiety during and after treatment for an HPV-related oropharyngeal cancer. Oral Oncol. 2016; 60: 90–95.CrossRefGoogle ScholarPubMed
Dodd, R, Forster, A, Waller, J, Marlow, L. Discussing HPV with oropharyngeal cancer patients: A cross-sectional survey of attitudes in health professionals. Oral Oncol. 2017; 68: 67–73.CrossRefGoogle ScholarPubMed
Shukla, A, Nyambose, J, Vanucci, R et al. Evaluating the effectiveness of human papillomavirus educational intervention among oral health professionals. J Cancer Educ. 2018; 34 (5): 890–896.CrossRefGoogle Scholar
Milbury, K, Rosenthal, D, El-Naggar, A, Badr, H. An exploratory study of the informational and psychosocial needs of patients with human papillomavirus-associated oropharyngeal cancer. Oral Oncol. 2013; 49 (11): 1067–1071.CrossRefGoogle ScholarPubMed
Inglehart, R, Taberna, M, Pickard, R et al. HPV knowledge gaps and information seeking by oral cancer patients. Oral Oncol. 2016; 63: 23–29.CrossRefGoogle ScholarPubMed
Chu, A, Genden, E, Posner, M, Sikora, A. A patient-centered approach to counseling patients with head and neck cancer undergoing human papillomavirus testing: a clinician’s guide. Oncologist. 2013; 18 (2): 180–189.CrossRefGoogle ScholarPubMed
Dodd, R, Forster, A, Marlow, L, Waller, J. Psychosocial impact of human papillomavirus-related head and neck cancer on patients and their partners: a qualitative interview study. Euro J Cancer. 2019; 28 (2): e12999.CrossRefGoogle ScholarPubMed
Baxi, S, Shuman, A, Corner, G et al. Sharing a diagnosis of HPV-related head and neck cancer: the emotions, the confusion, and what patients want to know. Head Neck. 2012; 35 (11): 1534–1541.CrossRefGoogle ScholarPubMed
Health and care professions council (HCPC). Standards of conduct, performance and ethics [Internet]. 2016. Available from: https://www.hcpc-uk.org/standards/standards-of-conduct-performance-and-ethics/. Accessed on 23rd June 2020Google Scholar
Ellis, E, Ferrer, R, Klein, W. Factors beyond lack of knowledge that predict “i don’t know” responses to surveys that assess HPV knowledge. J Health Commun. 2018; 23 (10–11): 967–976.CrossRefGoogle ScholarPubMed
Duncan, C G, Wakeham, K, Langley, R, Vale, C. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta analysis. Br J Cancer 2019; 120: 256–268.Google Scholar